| Management of Crohn disease: a review K Cushing, PDR Higgins Jama 325 (1), 69-80, 2021 | 206 | 2021 |
| Depression is associated with more aggressive inflammatory bowel disease B Kochar, EL Barnes, MD Long, KC Cushing, J Galanko, CF Martin, ... Official journal of the American College of Gastroenterology| ACG 113 (1), 80-85, 2018 | 166 | 2018 |
| Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis JE Gudjonsson, LC Tsoi, F Ma, AC Billi, KR Van Straalen, A Vossen, ... JCI insight 5 (19), 2020 | 117 | 2020 |
| Butyrate and mucosal inflammation: new scientific evidence supports clinical observation K Cushing, DM Alvarado, MA Ciorba Clinical and translational gastroenterology 6 (8), e108, 2015 | 100 | 2015 |
| Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study T Adar, D Faleck, S Sasidharan, K Cushing, NZ Borren, N Nalagatla, ... Alimentary pharmacology & therapeutics 49 (7), 873-879, 2019 | 87 | 2019 |
| Gastrointestinal bleeding following LVAD placement from top to bottom K Cushing, V Kushnir Digestive diseases and sciences 61, 1440-1447, 2016 | 81 | 2016 |
| Tofacitinib for biologic-experienced hospitalized patients with acute severe ulcerative colitis: a retrospective case-control study JA Berinstein, JL Sheehan, M Dias, EM Berinstein, CA Steiner, ... Clinical Gastroenterology and Hepatology 19 (10), 2112-2120. e1, 2021 | 80 | 2021 |
| A founder mutation in LEPRE1 carried by 1.5% of West Africans and 0.4% of African Americans causes lethal recessive osteogenesis imperfecta WA Cabral, AM Barnes, A Adeyemo, K Cushing, D Chitayat, FD Porter, ... Genetics in medicine 14 (5), 543-551, 2012 | 67 | 2012 |
| Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission KC Cushing, W Tan, DH Alpers, V Deshpande, AN Ananthakrishnan Alimentary pharmacology & therapeutics 51 (3), 347-355, 2020 | 57 | 2020 |
| Sarcopenia is a novel predictor of the need for rescue therapy in hospitalized ulcerative colitis patients KC Cushing, H Kordbacheh, MS Gee, A Kambadakone, ... Journal of Crohn's and Colitis 12 (9), 1036-1041, 2018 | 57 | 2018 |
| Safety and efficacy of tumor necrosis factor antagonists in older patients with ulcerative colitis: patient-level pooled analysis of data from randomized trials D Cheng, KC Cushing, T Cai, AN Ananthakrishnan Clinical Gastroenterology and Hepatology 19 (5), 939-946. e4, 2021 | 31 | 2021 |
| AXL is a potential target for the treatment of intestinal fibrosis CA Steiner, ES Rodansky, LA Johnson, JA Berinstein, KC Cushing, ... Inflammatory bowel diseases 27 (3), 303-316, 2021 | 28 | 2021 |
| PNPLA3 genotype and diabetes identify patients with nonalcoholic fatty liver disease at high risk of incident cirrhosis VL Chen, A Oliveri, MJ Miller, K Wijarnpreecha, X Du, Y Chen, ... Gastroenterology 164 (6), 966-977. e17, 2023 | 26 | 2023 |
| Vedolizumab as a novel treatment for refractory collagenous colitis: a case report KC Cushing, M Mino-Kenudson, J Garber, P Lochhead, H Khalili Official journal of the American College of Gastroenterology| ACG 113 (4 …, 2018 | 25 | 2018 |
| Predicting risk of postoperative disease recurrence in Crohn’s disease: patients with indolent Crohn’s disease have distinct whole transcriptome profiles at the time of first … KC Cushing, R Mclean, KG McDonald, JK Gustafsson, KA Knoop, ... Inflammatory bowel diseases 25 (1), 180-193, 2019 | 21 | 2019 |
| Breath methane levels are increased among patients with diverticulosis C Yazici, DC Arslan, R Abraham, K Cushing, A Keshavarzian, EA Mutlu Digestive diseases and sciences 61, 2648-2654, 2016 | 21 | 2016 |
| Novel genetic risk variants can predict anti-TNF agent response in patients with inflammatory bowel disease MH Wang, JJ Friton, LE Raffals, JA Leighton, SF Pasha, MF Picco, ... Journal of Crohn's and Colitis 13 (8), 1036-1043, 2019 | 17 | 2019 |
| Unique phenotypic characteristics and clinical course in patients with ulcerative colitis and primary sclerosing cholangitis: a multicenter US experience MH Wang, OY Mousa, JJ Friton, LE Raffals, JA Leighton, SF Pasha, ... Inflammatory bowel diseases 26 (5), 774-779, 2020 | 16 | 2020 |
| Hepatic decompensation is accelerated in patients with cirrhosis and alpha-1 antitrypsin Pi∗ MZ genotype VL Chen, DA Burkholder, IJ Moran, JV DiBattista, MJ Miller, Y Chen, X Du, ... JHEP Reports 4 (6), 100483, 2022 | 12 | 2022 |
| Smoking Interacts With CHRNA5, a Nicotinic Acetylcholine Receptor Subunit Gene, to Influence the Risk of IBD-Related Surgery KC Cushing, A Chiplunker, A Li, YJ Sung, T Geisman, LS Chen, S Cresci, ... Inflammatory bowel diseases 24 (5), 1057-1064, 2018 | 8 | 2018 |
